🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To evaluate the efficacy of dupilumab in children 6 to ...
Status
Completed
Location
Investigational Site Number 840031
Start Date
2017-04-21
Trial ID
NCT02948959
Treatments Being Tested
This study planned to assess the effect on the reduction in rate of severe ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2015-09
Trial ID
NCT02336425
This study investigated asthma-related quality of life in Brazilian patient...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-11
Trial ID
NCT00567476
The main goal of this study is to evaluate the efficacy and safety of glyco...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-02-14
Trial ID
NCT01985334
Treatments Being Tested
The primary objective is to compare the effectiveness of maintenance therap...
Status
Completed
Location
HealthCore, Inc.
Start Date
2019-11-01
Trial ID
NCT04138758
Treatments Being Tested
This study evaluates the efficacy and safety of benralizumab as an add-on t...
Status
Recruiting
Location
Research Site
Start Date
2025-03-28
Trial ID
NCT06750289
Treatments Being Tested
Increase in inhaled corticosteroid dose vs triple therapy in T2-high asthma...
Status
Withdrawn
Location
Hospital Universitario de A Coruña
Start Date
2023-06-01
Trial ID
NCT05919394
Treatments Being Tested
To assess the comparative effectiveness of combination Tiotropium and Oloda...
Status
Completed
Location
HealthCore, Inc.
Start Date
2019-11-01
Trial ID
NCT04184297
To asses effectiveness and safety of tezepelumab in adult and adolescent pa...
Status
Completed
Location
Research Site
Start Date
2022-04-29
Trial ID
NCT05329194
Treatments Being Tested
This is a multicentre, randomised, open-label, parallel-group, active-contr...
Status
Completed
Location
Research Site
Start Date
2020-07-27
Trial ID
NCT04159519
Treatments Being Tested